A Study to Determine the Effect of Multiple Oral Doses and Regimens of KD025 in Healthy Male and Post-menopausal Female Subjects

Clinical trial NCT05918588 · COMPLETED

Trial details

NCT number: NCT05918588
Sponsor: Kadmon, a Sanofi Company
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Immune System Disorder (Healthy Volunteer)

Start date: 2013-11-21
Primary completion: 2014-03-06
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.